On the morning of October 12, 2021 China biomaterials Conference opened in Shanghai International Convention Center. Jiao Hong, director of the State Drug Administration, Huang Yongping, Deputy Secretary General of the Shanghai Municipal People's government, Wang Yingjun, chairman of the Chinese society of biomaterials and academician of the Chinese Academy of engineering, Zhang Xingdong, honorary chairman of the Chinese society of biomaterials, academician of the Chinese Academy of engineering and foreign academician of the National Academy of engineering of the United States, and Cheng Danhong, Secretary of the Party committee of Shanghai University, attended the opening ceremony and delivered a speech.
Gao Ruiping, deputy director of NSFC, Fu Xiaobing, former chairman of China biomaterials society and academician of Chinese Academy of engineering, Liu Changsheng, chairman designate of China biomaterials society, academician of Chinese Academy of Sciences and President of Shanghai University, Chen Xuesi, academician of Chinese Academy of Sciences, sun Lei, director of medical device technical evaluation center of national drug administration, Wu Qiang, deputy district head of Shanghai Pudong New Area, Mao Lijuan, deputy director of Shanghai Municipal Education Commission, Wu Weiping, party secretary and director of Shanghai Pudong New Area market supervision and Administration Bureau, Zhu Weihong, vice president of East China University of technology, and Shen Jian, chairman of the board of supervisors of China biomaterials society attended the opening ceremony. The opening ceremony was presided over by Zhang Shengmin, vice president of China biomaterials society.
Jiao Hong pointed out that drug safety is related to people's health and well-being, the overall situation of economic development and social harmony and stability. The Party Central Committee and the State Council attach great importance to it. In recent years, the State Food and drug administration has continued to deepen reform, supported and encouraged scientific and technological innovation and application of biomaterials, helped tackle key core technologies in the industry, made every effort to serve and promote the implementation of the healthy China strategy. She hopes that everyone will follow the trend of scientific and technological innovation in accordance with the "four aspects" of scientific and technological work, firmly grasp the innovation source of basic research, strengthen open cooperation and stimulate the creative vitality of industrial innovation. She also hopes that the China biomaterials conference will continue to play a platform role, build a first-class comprehensive academic exchange platform and spare no effort to promote the development of biomaterial science and industrial innovation.
Zhang Xingdong said that the R & D and production of Biomedical Materials in China started late, but science, technology and industry have developed very rapidly in recent years. Today's biomaterial industry is integrating with emerging industries such as big data, artificial intelligence and 5g, and has become one of the pillar industries of national economic development.
Jinbo biology has always been committed to the scientific research of humanized collagen innovative biomaterials, because collagen is an important part of human tissue and plays an important role in human tissue repair. So far, the vast majority of medical collagen is from animals. How to eliminate its immunogenicity has always been the bottleneck of the development of collagen industry, and the recombinant humanized collagen using genetic engineering technology is an ideal way to solve the problem of immunogenicity. At the 2021 China biomaterials conference, we also showed the scientific research achievements of this innovative material.
From 10:00 to 12:20 on the same day, the "forum on recombinant collagen industry and supervision" was held. The sub Forum gathered industry experts to focus on the R & D, application, supervision and industrialization of humanized collagen, and further discuss and analyze the future development direction of humanized collagen.
Sourse:Latest Life Encyclopedia
Rimless Industry Co.,Ltd.